Screening Children in Clinics for Early Type 1 Diabetes
Studies whether routine checkups can include screening children for early type 1 diabetes.
Plain-language title generated from the registry record
Registry title: Universal Type 1 Diabetes Screening in Pediatrics
Key facts
- Where
- Alexander City, Bay Shore, Birmingham, Bloomfield Township, Commack, Detroit, Orlando, and Southfield, United StatesSee the 8 sites
Where in United States
- Pediatric Associates of Alexander CityAlexander City, United StatesNo longer taking part
- RBK Pediatrics - Bay ShoreBay Shore, United StatesNo longer taking part
- Bloom Pediatrics - BirminghamBirmingham, United StatesNo longer taking part
- Bloom Pediatrics - BloomfieldBloomfield Township, United StatesNo longer taking part
- RBK Pediatrics - CommackCommack, United StatesNo longer taking part
- Bloom Pediatrics - DetroitDetroit, United StatesNo longer taking part
- Pediatrics of Greater OrlandoOrlando, United StatesNo longer taking part
- Bloom Pediatrics - SouthfieldSouthfield, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Northwestern University
- Trial code
- NCT07612475
- Record updated
- 15 October 2026
- Original description
This study examines how population-based screening for type 1 diabetes (T1D) using islet autoantibodies (i.e., immune system proteins) can be incorporated into pediatric primary care during routine well-child visits. The project evaluates whether this screening approach, supported by the study's implementation approach, is feasible, acceptable, and appropriate for clinicians, parents, and other key constituent groups. The study also explores how often clinicians order the test, how often patients complete it, and how often clinicians document stages of early-stage T1D in the patients' electronic health records. Insights from parents, clinicians, other care team members, pediatric endocrinologists, and national and regional experts will inform future scale-up efforts and practical strategies to improve early detection of T1D in pediatric practices across the United States.Read full original descriptionShow less
Feasibility of Implementing Type One Diabetes Screening in Pediatric Clinics
This study examines how population-based screening for type 1 diabetes (T1D) using islet autoantibodies (i.e., immune system proteins) can be incorporated into pediatric primary care during routine well-child visits. The project evaluates whether this screening approach, supported by the study's implementation approach, is feasible, acceptable, and appropriate for clinicians, parents, and other key constituent groups. The study also explores how often clinicians order the test, how often patients complete it, and how often clinicians document stages of early-stage T1D in the patients' electronic health records. Insights from parents, clinicians, other care team members, pediatric endocrinologists, and national and regional experts will inform future scale-up efforts and practical strategies to improve early detection of T1D in pediatric practices across the United States.
Inclusion: Children; Clinics will be encouraged to select screening ages or visits that align with international consensus statements for screening during early childhood, mid-childhood, and preadolescence and routine U.S. well-child visit schedules, and that minimize workflow disruption and maximize screening completion, such as visits that already include blood draws for other routine tests (e.g., lead screening at age 2). Children who have visits at their clinic's selected ages will be eligible to have their data extracted from the electronic health record (EHR); Parents/Caregivers - All parents or legal guardians (hereafter, parents) who attended the well-child visit, who are eligible to have their child's EHR data extracted, and who are over age 18, will be eligible to complete the post-visit survey and interview; Clinicians and Other Care Team Members; All pediatric primary care clinicians (i.e., physician [MD, DO], nurse practitioner, physician assistant) at participating clinics will be eligible to complete an interview; All other care team members, including nurses, medical assistants, phlebotomists, and front desk staff at participating clinics will be eligible to complete an interview.
Exclusion: Parents who have opted-out of survey recruitment at their clinic will not be eligible for the survey/interview.